ArticlePloS one2014
Utilizing nanobody technology to target non-immunodominant domains of VAR2CSA.
Sisse B Ditlev et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
12 papers cite it
this papercites it
ArticlePloS one2014
Sisse B Ditlev et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.